Home > Clinical Trials
Check All Search

Saved trials

Terminated
NCT04516941
CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19
60 Enrollment(s)
5 Study location(s)
Interventional (Phase III)
SARS-CoV Infection
COVID-19
Active, not recruiting
NCT04730037
Clinical Trial to Investigate Safety and Efficacy of Edoxaban in Patients With CTEPH (KABUKI)
74 Enrollment(s)
1 Study location(s)
Interventional (Phase III)
CTEPH
Terminated
NCT05091528
A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers
2 Enrollment(s)
1 Study location(s)
Interventional (Phase I|Phase II)
HER2-positive Breast Cancer
HER2-positive Gastric Cancer
HER2-positive Colorectal Cancer
HER2-expressing Non-small Cell Lung Cancer
Active, not recruiting
NCT03895502
Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study
605 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Venous Thrombosis
Neoplasms
Anticoagulant
Completed
NCT03247582
Edoxaban Treatment in Routine Clinical Practice for Patients With Non-valvular Atrial Fibrillation (ETNA-AF-Hong Kong)
234 Enrollment(s)
4 Study location(s)
Observational
Atrial Fibrillation
Recruiting
NCT05189015
Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and Hypertension
80 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Angiotensin/Renin/Aldosterone Hypertension
Hypertension
Diabetes Mellitus, Type 2
Completed
NCT03524924
Edoxaban and Frailty in Senior Individuals
180 Enrollment(s)
1 Study location(s)
Observational
Atrial Fibrillation
Active, not recruiting
NCT05491460
Pharmacokinetics and Point of Care Testing of Direct Oral Anticoagulants Subjects
24 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Anticoagulant Therapy